Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety and immunovirologic outcomes with maraviroc combination regimens in patients with a history of past treatment failures and virologic resistance in Brazil: an open-label, multicenter phase 3b study.
AIDS Res Hum Retroviruses. 2013 Sep;29(9):1203-10. doi: 10.1089/AID.2012.0330. Epub 2013 Jun 25.
AIDS Res Hum Retroviruses. 2013.
PMID: 23731330
Clinical Trial.
Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil.
Sprinz E, Netto EM, Patelli M, Lima JS, Furtado JJ, da Eira M, Zajdenverg R, Madruga JV, Lewi DS, Machado AA, Pedro RJ, Soares MA.
Sprinz E, et al. Among authors: da eira m.
AIDS Res Hum Retroviruses. 2009 Sep;25(9):861-7. doi: 10.1089/aid.2009.0012.
AIDS Res Hum Retroviruses. 2009.
PMID: 19689190
Item in Clipboard
In-vivo selection of the mutation F121Y in a patient failing raltegravir containing salvage regimen.
Souza Cavalcanti J, Minhoto Lança A, de Paula Ferreira JL, da Eira M, de Souza Dantas DS, de Macedo Brígido LF.
Souza Cavalcanti J, et al. Among authors: da eira m.
Antiviral Res. 2012 Jul;95(1):9-11. doi: 10.1016/j.antiviral.2012.04.007. Epub 2012 May 4.
Antiviral Res. 2012.
PMID: 22564967
Free article.
Item in Clipboard
Transmitted Drug Resistance Among Recently Diagnosed Adults and Children in São Paulo, Brazil.
Guimarães PM, Ferreira JL, Coelho LP, Cavalcanti Jde S, Lopes GI, Matsuda EM, Almeida FJ, Almeida VC, Campeas AE, Junior LC, Brígido LF; Sa˜o Paulo Salvage Workgroup.
Guimarães PM, et al.
AIDS Res Hum Retroviruses. 2015 Dec;31(12):1219-24. doi: 10.1089/AID.2014.0354. Epub 2015 May 4.
AIDS Res Hum Retroviruses. 2015.
PMID: 25826640
Item in Clipboard
Gastrointestinal tolerability and quality of life in antiretroviral-naive HIV-1-infected patients: data from the CASTLE study.
Malan N, Su J, Mancini M, Yang R, Wirtz V, Absalon J, McGrath D; CASTLE Study Team.
Malan N, et al.
AIDS Care. 2010 Jun;22(6):677-86. doi: 10.1080/09540120903334641.
AIDS Care. 2010.
PMID: 20467943
Clinical Trial.
Item in Clipboard
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study.
Molina JM, Andrade-Villanueva J, Echevarria J, Chetchotisakd P, Corral J, David N, Moyle G, Mancini M, Percival L, Yang R, Thiry A, McGrath D; CASTLE Study Team.
Molina JM, et al.
Lancet. 2008 Aug 23;372(9639):646-55. doi: 10.1016/S0140-6736(08)61081-8.
Lancet. 2008.
PMID: 18722869
Clinical Trial.
Item in Clipboard
Cite
Cite